Details for Patent: 8,956,647
✉ Email this page to a colleague
Summary for Patent: 8,956,647
| Title: | Pellet formulation for the treatment of the intestinal tract |
| Abstract: | An orally administrable pharmaceutical pellet formulation for the treatment of the intestinal tract is disclosed, which comprises a core and an enteric coating, the core including, as a pharmaceutical active compound, aminosalicylic acid or a pharmaceutically tolerable salt or a derivative thereof. |
| Inventor(s): | Otterbeck; Norbert (Uberlingen, DE), Gruber; Peter (Merzhausen, DE) |
| Assignee: | Dr. Falk Pharma GmbH (DE) |
| Application Number: | 13/951,951 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; Compound; Dosage form; |
Drugs Protected by US Patent 8,956,647
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,956,647
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 241964 | ⤷ Sign Up | |||
| Canada | 2297832 | ⤷ Sign Up | |||
| Germany | 19732903 | ⤷ Sign Up | |||
| Germany | 59808642 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
